Cigna Corp (CGN) Stock Forecast, Price Targets and Analysts Predictions

CGN Analyst Ratings

Strong Buy

13 Buy

4 Hold

0 Sell

Based on 17 analysts giving stock ratings to

Cigna

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CGN Stock 12 Month Forecast

Average Price Target

―

Based on 17 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is CHF275.61 with a high forecast of CHF306.48 and a low forecast of CHF245.35. The average price target represents a ― change from the last price of ―.

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

Highest Price TargetCHF306.48

Average Price TargetCHF275.61

Lowest Price TargetCHF245.35

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lance Wilkes

Bernstein

CHF306.48

Buy

―

Assigned

08/28/26

Bernstein Gives a Buy Rating to Cigna (CI)

Jessica Tassan

Piper Sandler

CHF278.33

Buy

―

Reiterated

08/26/26

Piper Sandler Remains a Buy on Cigna (CI)

David Windley

Jefferies

CHF270.28→CHF246.95

Hold

―

Downgraded

08/03/26

Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies

Parker Snure

Raymond James

CHF281.54→CHF257.41

Buy

―

Reiterated

08/03/26

Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James

Scott Fidel

Goldman Sachs

CHF273.5→CHF283.15

Buy

―

Reiterated

08/02/26

Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)

Unknown Analyst

Oppenheimer

Not Ranked

Oppenheimer

CHF293.61

Buy

―

Reiterated

07/31/26

Oppenheimer Keeps Their Buy Rating on Cigna (CI)

Erin Wright

Morgan Stanley

CHF290.39

Buy

―

Reiterated

07/31/26

Morgan Stanley Sticks to Their Buy Rating for Cigna (CI)

David S Macdonald

Truist Financial

CHF281.54

Buy

―

Reiterated

07/31/26

Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Dexcom (DXCM)

George Hill

Deutsche Bank

CHF242.93→CHF245.35

Hold

―

Reiterated

07/31/26

Cigna price target raised to $305 from $302 at Deutsche BankCigna price target raised to $305 from $302 at Deutsche Bank

Stephen Baxter

Wells Fargo

CHF245.35→CHF246.95

Hold

―

Assigned

07/31/26

Stephen Baxter Maintains Hold on Cigna, Nudges Price Target Up to $307 Amid Strong Healthcare Performance but PBM Uncertainties

Michael Ha

Robert W. Baird

CHF271.09→CHF291.2

Buy

―

Reiterated

07/31/26

Cigna price target raised to $362 from $337 at BairdCigna price target raised to $362 from $337 at Baird

Andrew Mok CFA

Barclays

CHF244.54→CHF249.37

Hold

―

Reiterated

07/31/26

Barclays Sticks to Its Hold Rating for Cigna (CI)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

07/30/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ben Hendrix

RBC Capital

CHF271.09

Buy

―

Reiterated

07/30/26

RBC Capital Sticks to Its Buy Rating for Cigna (CI)

Jason Cassorla

Guggenheim

CHF271.89→CHF290.39

Buy

―

Reiterated

07/30/26

Cigna price target raised to $361 from $338 at GuggenheimCigna price target raised to $361 from $338 at Guggenheim

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lance Wilkes

Bernstein

CHF306.48

Buy

―

Assigned

08/28/26

Bernstein Gives a Buy Rating to Cigna (CI)

Jessica Tassan

Piper Sandler

CHF278.33

Buy

―

Reiterated

08/26/26

Piper Sandler Remains a Buy on Cigna (CI)

David Windley

Jefferies

CHF270.28→CHF246.95

Hold

―

Downgraded

08/03/26

Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies

Parker Snure

Raymond James

CHF281.54→CHF257.41

Buy

―

Reiterated

08/03/26

Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James

Scott Fidel

Goldman Sachs

CHF273.5→CHF283.15

Buy

―

Reiterated

08/02/26

Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)

Unknown Analyst

Oppenheimer

Not Ranked

Oppenheimer

CHF293.61

Buy

―

Reiterated

07/31/26

Oppenheimer Keeps Their Buy Rating on Cigna (CI)

Erin Wright

Morgan Stanley

CHF290.39

Buy

―

Reiterated

07/31/26

Morgan Stanley Sticks to Their Buy Rating for Cigna (CI)

David S Macdonald

Truist Financial

CHF281.54

Buy

―

Reiterated

07/31/26

Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Dexcom (DXCM)

George Hill

Deutsche Bank

CHF242.93→CHF245.35

Hold

―

Reiterated

07/31/26

Cigna price target raised to $305 from $302 at Deutsche BankCigna price target raised to $305 from $302 at Deutsche Bank

Stephen Baxter

Wells Fargo

CHF245.35→CHF246.95

Hold

―

Assigned

07/31/26

Stephen Baxter Maintains Hold on Cigna, Nudges Price Target Up to $307 Amid Strong Healthcare Performance but PBM Uncertainties

Michael Ha

Robert W. Baird

CHF271.09→CHF291.2

Buy

―

Reiterated

07/31/26

Cigna price target raised to $362 from $337 at BairdCigna price target raised to $362 from $337 at Baird

Andrew Mok CFA

Barclays

CHF244.54→CHF249.37

Hold

―

Reiterated

07/31/26

Barclays Sticks to Its Hold Rating for Cigna (CI)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

07/30/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ben Hendrix

RBC Capital

CHF271.09

Buy

―

Reiterated

07/30/26

RBC Capital Sticks to Its Buy Rating for Cigna (CI)

Jason Cassorla

Guggenheim

CHF271.89→CHF290.39

Buy

―

Reiterated

07/30/26

Cigna price target raised to $361 from $338 at GuggenheimCigna price target raised to $361 from $338 at Guggenheim

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ODTXOdyssey Therapeutics, Inc.

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

AMLXAmylyx Pharmaceuticals Inc

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

3 Months

Ann HynesMizuho Securities

Success Rate

17/28 ratings generated profit

Average Return

+4.32%

Copying Ann Hynes's trades and holding each position for 3 Months would result in 60.71% of your transactions generating a profit, with an average return of +4.32% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

22/32 ratings generated profit

Average Return

+15.84%

Copying Scott Fidel's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +15.84% per trade.

2 Years

Scott FidelGoldman Sachs

Success Rate

26/32 ratings generated profit

Average Return

+23.13%

Copying Scott Fidel's trades and holding each position for 2 Years would result in 81.25% of your transactions generating a profit, with an average return of +23.13% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CGN Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

0

Buy

28

25

30

21

Hold

2

4

7

5

Sell

0

Strong Sell

0

total

30

32

29

37

26

In the current month, CGN has received 21 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. CGN average Analyst price target in the past 3 months is 275.61.

Each month's total comprises the sum of three months' worth of ratings.

CGN Financial Forecast

CGN Earnings Forecast

Next quarter’s earnings estimate for CGN is CHF6.02 with a range of CHF5.95 to CHF6.25. The previous quarter’s EPS was CHF6.24. CGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CGN has Performed in-line its overall industry.

CGN Sales Forecast

Next quarter’s sales forecast for CGN is CHF58.25B with a range of CHF56.53B to CHF59.56B. The previous quarter’s sales results were CHF57.41B. CGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CGN has Performed in-line its overall industry.

CGN Stock Forecast FAQ

What is CH:CGN’s average 12-month price target, according to analysts?

Based on analyst ratings, Cigna Corp’s 12-month average price target is 275.61.

What is CH:CGN’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:CGN, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Cigna Corp a Buy, Sell or Hold?

Cigna Corp has a consensus rating of Strong Buy, which is based on 13 buy ratings, 4 hold ratings and 0 sell ratings.

What is Cigna Corp’s share price target?

The average share price target for Cigna Corp is 275.61. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF306.48 ,and the lowest forecast is CHF245.35. The average share price target represents N/A Increase from the current price of N/A.

What do analysts say about Cigna Corp?

Cigna Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of Cigna Corp?

To buy shares of CH:CGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Cigna (CGN) Stock Forecast & Price Target

CGN Analyst Ratings

CGN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cigna

CGN Analyst Recommendation Trends

CGN Financial Forecast

CGN Earnings Forecast

CGN Sales Forecast

CGN Stock Forecast FAQ

Detailed List of Analyst Forecasts